You have 9 free searches left this month | for more free features.

idiopathic refractory scleritis

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Idiopathic Refractory Scleritis Trial (Infliximab, Cyclophosphamide)

Withdrawn
  • Idiopathic Refractory Scleritis
  • (no location specified)
Jul 18, 2022

Urinary Bladder, Overactive Trial in Denizli (Transcutaneous tibial nerve stimulation (TTNS))

Not yet recruiting
  • Urinary Bladder, Overactive
  • Transcutaneous tibial nerve stimulation (TTNS)
  • Denizli, Turkey
    Pamukkale University
Dec 19, 2022

Urinary Bladder, Overactive Trial (intravaginal electrical stimulation added to bladder training)

Recruiting
  • Urinary Bladder, Overactive
  • intravaginal electrical stimulation added to bladder training
  • Denizli, Turkey
    Pamukkale Univercity
Oct 31, 2022

Refractory Systemic Lupus Erythematosus, Lupus Nephritis, Immune Thrombocytopenia Trial in Peking (CNCT19 cell injection)

Enrolling by invitation
  • Refractory Systemic Lupus Erythematosus
  • +2 more
  • CNCT19 cell injection
  • Peking, China
    Xiaofeng Zeng
Jul 3, 2023

Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Neuromyelitis Optica Spectrum Disorder Trial in Wuhan (CT103A

Recruiting
  • Autoimmune Diseases
  • +5 more
  • CT103A cells
  • Cyclophosphamide and fludarabine
  • Wuhan, Hubei, China
    Tongji Hospital affiliated to Tongji Medical College of Huazhong
Dec 10, 2022

Relapsed/Refractory Immune Thrombocytopenia Trial in Seoul (Bortezomib)

Not yet recruiting
  • Relapsed/Refractory Immune Thrombocytopenia
  • Seoul, Korea, Republic of
  • +1 more
Oct 30, 2022

Movement Disorders, Neurology, Parkinsons Disease Trial (Exablate Pallidotomy, Unilateral)

Not yet recruiting
  • Movement Disorders
  • +2 more
  • Exablate Pallidotomy, Unilateral
  • (no location specified)
Sep 13, 2022

Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy

Recruiting
  • Tremor Associated With Tremor Dominant Parkinson's Disease
  • Unilateral thalamotomy
  • Chicago, Illinois
  • +1 more
Aug 1, 2022

Activity and Safety of Fostamatinib in Consecutive Adult ITP

Not yet recruiting
  • ITP - Immune Thrombocytopenia
  • +2 more
  • (no location specified)
Jan 12, 2023

Sacral Neuromodulation in Idiopathic Slow-transit Constipation

Completed
  • Constipation
  • Surgery
  • Sacral Neuromodulation
  • Maastricht, Limburg, Netherlands
  • +1 more
Feb 3, 2022

Refractory Idiopathic Aplastic Anemia, Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation Trial (Allogenic

Not yet recruiting
  • Refractory Idiopathic Aplastic Anemia
  • Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation
  • Allogenic transplantation
  • (no location specified)
Nov 8, 2021

Gastroparesis Postoperative, Gastroparesis Due to Diabetes, Idiopathic Gastric Stasis Trial in Mexico (G-POEM)

Completed
  • Gastroparesis Postoperative
  • +2 more
  • G-POEM
  • Mexico, Mexico City, Mexico
    Centro Medico Nacional Siglo XXI Hospital de Especialidades
Jan 5, 2022

Immune Thrombocytopenia Trial (Daratumumab Injection)

Not yet recruiting
  • Immune Thrombocytopenia
  • Daratumumab Injection
  • (no location specified)
Sep 28, 2022

Parkinson's Disease Trial in United States (ExAblate Transcranial System)

Completed
  • Parkinson's Disease
  • ExAblate Transcranial System
  • Stanford, California
  • +4 more
Dec 20, 2021

Parkinson's Disease Trial in Charlottesville (ExAblate Transcranial System)

Active, not recruiting
  • Parkinson's Disease
  • ExAblate Transcranial System
  • Charlottesville, Virginia
    University of Virginia
Dec 19, 2022

Idiopathic Multicentric Castleman's Disease Trial in Beijing (Zanubrutinib)

Recruiting
  • Idiopathic Multicentric Castleman's Disease
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Feb 5, 2021

Immune Thrombocytopenia, Bruton's Tyrosine Kinase Trial (Orelabrutinib)

Not yet recruiting
  • Immune Thrombocytopenia
  • Bruton's Tyrosine Kinase
  • (no location specified)
Aug 18, 2021

Thrombocytopenia, Mesenchymal Stem Cells Trial in Tianjin (Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs))

Recruiting
  • Thrombocytopenia
  • Mesenchymal Stem Cells
  • Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs)
  • Tianjin, Tianjin, China
    Yunfei Chen
Jun 30, 2021

Autoimmune Hemolytic Anemia, Autoimmune Hemolytic Anemia and Autoimmune Thrombocytopenia Trial in Beijing (combination of a

Recruiting
  • Autoimmune Hemolytic Anemia
  • Autoimmune Hemolytic Anemia and Autoimmune Thrombocytopenia
  • combination of a single dose anti-CD20 antibody and bortezomib
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Oct 12, 2021

Idiopathic Multicentric Castleman's Disease Trial in Lansing (Siltuximab)

Terminated
  • Idiopathic Multicentric Castleman's Disease
  • Lansing, Michigan
    Edward W. Sparrow Hospital
Apr 15, 2021

Idiopathic Intracranial Hypertension (IIH) Trial in New York (Venous Sinus Stenting)

Completed
  • Idiopathic Intracranial Hypertension (IIH)
  • Venous Sinus Stenting
  • New York, New York
    New York Presbyterian/ Weill Cornell Medicine
Jul 31, 2020

Tremor, Essential, Neurologic Manifestations, Tremor Trial in Toronto, Seoul (ExAblate)

Active, not recruiting
  • Tremor, Essential
  • +2 more
  • ExAblate
  • Toronto, Ontario, Canada
  • +1 more
Sep 15, 2021

Gastroparesis Trial (Enterra Gastric Pacemaker)

Withdrawn
  • Gastroparesis
  • Enterra Gastric Pacemaker
  • (no location specified)
Mar 3, 2021

Urinary Bladder, Overactive Trial in France (Unilateral electrode placement and testing, Bilateral electrode placement and

Completed
  • Urinary Bladder, Overactive
  • Unilateral electrode placement and testing
  • Bilateral electrode placement and testing
  • Montpellier, France
  • +5 more
Aug 3, 2020

Parkinson's Disease Trial in Charlottesville, Seattle (ExAblate Transcranial MRgFUS, Sham ExAblate Transcranial MRgFUS)

Completed
  • Parkinson's Disease
  • ExAblate Transcranial MRgFUS
  • Sham ExAblate Transcranial MRgFUS
  • Charlottesville, Virginia
  • +1 more
Sep 17, 2020